NVDA
NVIDIA Corporation
NVDA's fundamentals are strong and it looks cheap: trading at 21x earnings, about a third of its usual 65x. Analysts expect strong earnings growth.
PHUN
Phunware, Inc.
There isn't enough reported data to score PHUN yet.
NVDA Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Strong | |
| Strong | |
| Strong |
NVDA's revenue, profitability, cash flow and balance sheet are all currently strong.
PHUN Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Weak | |
| Weak | |
| Unavailable |
PHUN's revenue is currently healthy, but its profitability and cash flow are weak. There isn't enough data to rate its balance sheet.
NVDA PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 12x | $166 | — |
| Current | 21x | $166 | — |
| Cheap | 44x | $345 | +108% |
| Fair | 65x | $511 | +207% |
| Expensive | 93x | $734 | +342% |
Historical ranges are pointers, not guarantees.
NVDA's PE is in its cheap range at 21x. If earnings grow as analysts expect, today's price would be 12x next year's earnings.
PHUN PE Valuation
PHUN has no meaningful PE right now: it lost money over the past year.
NVDA Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Strong growth | |
| Weakening | |
| Broad | |
| Moderate |
Analysts expect strong earnings and revenue growth for NVDA, but weaker profitability.
PHUN Forward outlook
There aren't enough analyst estimates for PHUN to show an outlook.
NVDA Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $13.77 | +74% |
| Q3 2026 | $7.91 | +125% |
| Q2 2026 | $6.53 | +111% |
| Q1 2026 | $4.90 | +67% |
| Q4 2025 | $4.03 | +59% |
| Q3 2025 | $3.51 | +65% |
| Q2 2025 | $3.10 | +81% |
| Q1 2025 | $2.94 | +147% |
| Q4 2024 | $2.54 | +234% |
NVDA has the stronger earnings trend. Trailing diluted EPS is up 125% for NVDA versus PHUN down 104%.
PHUN Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2024 | -$10.08 | +$8.42 |
| Q2 2024 | -$17.83 | -$3.33 |
| Q1 2024 | -$20.51 | -$0.51 |
| Q4 2023 | -$22.18 | +$3.32 |
| Q3 2023 | -$18.50 | +$20.50 |
| Q2 2023 | -$14.50 | +$20.50 |
| Q1 2023 | -$20.00 | +$12.50 |
| Q4 2022 | -$25.50 | +$9.00 |
PHUN is still losing money, but far less than before: $0.65 per share over the past year, against $39.00 at its worst in late 2022.
NVDA Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $96.2B | +106% |
| Q2 2026 | $81.6B | +85% |
| Q1 2026 | $68.1B | +73% |
| Q4 2025 | $57B | +62% |
| Q3 2025 | $46.7B | +56% |
| Q2 2025 | $44.1B | +69% |
| Q1 2025 | $39.3B | +78% |
| Q4 2024 | $35.1B | +94% |
NVDA has the edge over PHUN on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 66% | +5.4 points |
| Q2 2026 | 66% | +17 points |
| Q1 2026 | 65% | +3.9 points |
| Q4 2025 | 63% | +0.8 points |
| Q3 2025 | 61% | -1.2 points |
| Q2 2025 | 49% | -16 points |
| Q1 2025 | 61% | -0.5 points |
| Q4 2024 | 62% | +4.9 points |
NVDA has the edge over PHUN on profitability, with a higher operating margin.
PHUN Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q2 2026 | $799K | +76% |
| Q1 2026 | $542K | -21% |
| Q4 2025 | $788K | +33% |
| Q3 2025 | $622K | -6.5% |
| Q2 2025 | $455K | -55% |
| Q1 2025 | $688K | -25% |
| Q3 2024 | $665K | -76% |
| Q2 2024 | $1M | -71% |
PHUN's revenue is recovering but still below its 2022 peak: $799,000 last quarter, up 76% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q2 2026 | -757% | +179 points |
| Q1 2026 | -742% | -42 points |
| Q4 2025 | -1008% | -182 points |
| Q3 2025 | -563% | -83 points |
| Q2 2025 | -936% | -646 points |
| Q1 2025 | -700% | -388 points |
| Q4 2024 | -826% | N/A |
| Q3 2024 | -480% | +184 points |
PHUN's operating margin was −757% last quarter, up 179 points from the same quarter a year ago.
NVDA Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $21.4B | +59% |
| Q2 2026 | $48.6B | +86% |
| Q1 2026 | $34.9B | +124% |
| Q4 2025 | $22.1B | +32% |
| Q3 2025 | $13.5B | -0.3% |
| Q2 2025 | $26.2B | +75% |
| Q1 2025 | $15.6B | +38% |
| Q3 2024 | $13.5B | +113% |
NVDA has the edge over PHUN on cash generation, producing positive trailing cash flow while its opponent burns cash.
PHUN Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q2 2026 | -$5.7M | -$2.3M |
| Q1 2026 | -$2.7M | +$608K |
| Q4 2025 | -$3.2M | -$484K |
| Q3 2025 | -$2.5M | -$96K |
| Q2 2025 | -$3.5M | -$780K |
| Q1 2025 | -$3.3M | +$2.2M |
| Q4 2024 | -$2.7M | -$146K |
| Q3 2024 | -$2.4M | +$924K |
PHUN has burned cash in almost every quarter: −$14M over the past year, against −$12M the year before.
NVDA Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.4% | -106M shares |
| 1 year | -1% | -247M shares |
| 3 years | -2.8% | -705M shares |
| 5 years | -4.1% | -1B shares |
| Available history | -1.8% | -435M shares |
NVDA has the edge over PHUN on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $19.7B |
| Q2 2026 | $19.3B |
| Q1 2026 | $3.8B |
| Q4 2025 | $12.5B |
| Q3 2025 | $9.7B |
| Q2 2025 | $14.1B |
| Q1 2025 | $7.8B |
| Q4 2024 | $11B |
NVDA spent $55.3B buying back its own shares over the past year, up 30% from the year before.
PHUN Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +1.2% | +243K shares |
| 1 year | +1.3% | +260K shares |
| 3 years | +932% | +18.5M shares |
| 5 years | +2340% | +19.6M shares |
PHUN has 20M diluted shares, up 1.3% from a year ago.
| Quarter | Spent |
|---|---|
| Q1 2024 | — |
| Q4 2023 | — |
| Q3 2023 | — |
| Q2 2023 | $27,000 |
| Q1 2023 | $475,000 |
NVDA Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 0.1x | Very low |
| Q2 2026 | -0.0x | Net Cash |
| Q1 2026 | -0.0x | Net Cash |
| Q4 2025 | -0.0x | Net Cash |
| Q3 2025 | -0.0x | Net Cash |
| Q2 2025 | -0.1x | Net Cash |
| Q1 2025 | -0.0x | Very low |
| Q4 2024 | -0.0x | Net Cash |
NVDA's net debt is less than a year of its operating earnings (EBITDA), after holding more cash than debt a year ago.
PHUN Net Leverage
PHUN's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
NVDA Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 33.4 | Neutral |
| Stochastic | 18.1 | Oversold |
NVDA's weekly RSI is 33 (neutral) and its Stochastic is 18 (oversold).
PHUN Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 34.1 | Neutral |
| Stochastic | 15.3 | Oversold |
PHUN's weekly RSI is 34 (neutral) and its Stochastic is 15 (oversold).
NVDA PE vs Technology Sector
| Metric | NVDA | Sector median | Relative |
|---|---|---|---|
| PE | 21x | 28x | 25% below |
| PE % | 0 | 35 | 35 pts below |
NVDA is trading at 21x earnings, a 25% discount to the Technology sector's median of 28x.
PHUN PE vs Technology Sector
PHUN has no meaningful PE right now: it lost money over the past year.
NVDA Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $208.9 | 20% below |
| 20 week MA | $212.0 | 22% below |
| 50 week MA | $199.9 | 17% below |
| 100 week MA | $175.1 | 5.1% below |
| 200 week MA | $123.6 | 34% above |
NVDA has the edge over PHUN on trend strength, trading above more of its moving averages.
PHUN Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $1.93 | 9.8% below |
| 20 week MA | $2.02 | 14% below |
| 50 week MA | $1.96 | 11% below |
| 100 week MA | $2.56 | 32% below |
| 200 week MA | $8.89 | 80% below |
PHUN is in a downtrend: it's below all five of its weekly moving averages, and 80% below its 200-week average.
NVDA Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $5.92 | $13.0 | +119% |
| 2021 | $13.0 | $29.6 | +128% |
| 2022 | $29.6 | $15.2 | -49% |
| 2023 | $15.2 | $49.5 | +226% |
| 2024 | $49.5 | $137.0 | +177% |
| 2025 | $137.0 | $190.5 | +39% |
| 2026 YTD | $190.5 | $166.2 | -13% |
NVDA's yearly returns have swung widely, from +226% in 2023 to −49% in 2022. It's down 13% so far in 2026.
PHUN Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $59.0 | $50.5 | -14% |
| 2021 | $50.5 | $153.0 | +203% |
| 2022 | $153.0 | $39.1 | -74% |
| 2023 | $39.1 | $4.10 | -90% |
| 2024 | $4.10 | $5.73 | +40% |
| 2025 | $5.73 | $1.92 | -66% |
| 2026 YTD | $1.92 | $1.74 | -9.4% |
PHUN has the edge over NVDA on returns for 2026, with the stronger performance.